Beta Bionics Raises FY2026 Sales Guidance from $130.000M-$135.000M to $131.000M-$136.000M vs $132.590M Est

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Beta Bionics (NASDAQ:BBNX) raises FY2026 sales outlook from $130.000 million-$135.000 million to $131.000 million-$136.000 million vs $132.590 million estimate.